The Czech Home Parenteral Nutrition Registry REDNUP: Comprehensive Analysis of Adult Patients' Data

Ann Nutr Metab. 2024;80(3):143-152. doi: 10.1159/000538232. Epub 2024 Mar 12.

Abstract

Introduction: Home parenteral nutrition (HPN) is the primary treatment modality for patients with chronic intestinal failure, one of the least common organ failures. This article provides a retrospective analysis of the data collected on HPN patients in the Czech Republic over the past 30 years.

Methods: National registry data were collected using a standardised online form based on the OASIS registry (Oley - A.S.P.E.N. Information System) across all centres providing HPN in the Czech Republic. Data collected prospectively from adult patients in the HPN program were analysed in the following categories: epidemiology, demographics, underlying syndrome, diagnosis, complications, and teduglutide therapy prevalence.

Results: The registry identified a total of 1,838 adult patient records, reflecting almost 1.5 million individual catheter days. The prevalence of HPN has risen considerably over the last few decades, currently reaching 5.5 per 100,000 population. The majority of patients have short bowel syndrome and GI obstruction, with cancer being the most prevalent underlying disease. Catheter-related bloodstream infections have been the most prevalent acute complication. However, the incidence in 2022 was only 0.15 per 1,000 catheter days. The study also observed an increase in the prevalence of patients on palliative HPN over the last decade.

Conclusion: This study presents a thorough analysis of data from the Czech REgistr Domaci NUtricni Podpory (REDNUP) registry. It shows an increasing prevalence of HPN, namely, in the palliative patient group. The sharing of national data can improve understanding of this rare condition and facilitate the development of international guidelines.

Keywords: Chronic intestinal failure; Epidemiology; Home parenteral nutrition; National registry.

MeSH terms

  • Adult
  • Aged
  • Catheter-Related Infections / epidemiology
  • Czech Republic / epidemiology
  • Female
  • Humans
  • Intestinal Failure / epidemiology
  • Intestinal Failure / therapy
  • Male
  • Middle Aged
  • Parenteral Nutrition, Home* / statistics & numerical data
  • Peptides / administration & dosage
  • Prevalence
  • Registries*
  • Retrospective Studies
  • Short Bowel Syndrome / therapy
  • Young Adult

Substances

  • teduglutide
  • Peptides

Grants and funding

REDNUP was supported by Baxter Czech Ltd. and Takeda Pharmaceuticals Czech Republic Ltd. J.G. was supported by the EFSD Mentorship Programme supported by AstraZeneca and EU LX22NPO5104, EXCELES projects.